Design and Characterization of Ricin Based Immunotoxins Against EPHA2 Receptor for Breast Cancer Therapy: An...

Area of Science:

• Biochemistry
• Molecular Biology
• Immunology

Background:

• Immunotoxins represent a promising strategy for cancer therapy.
• The EphA2 receptor is overexpressed in breast cancer, making it a potential therapeutic target.

Purpose of the Study:

• To design and computationally evaluate two novel immunotoxins targeting the EphA2 receptor for breast cancer treatment.
• To assess the stability, binding affinity, and safety profiles of the designed immunotoxins.

Main Methods:

• Constructing immunotoxins by fusing anti-EphA2 single-chain variable fragments (scFv) with ricin A chain.
• Utilizing bioinformatics tools (mFold, HADDOCK, Gromacs) for mRNA stability, protein structure prediction, molecular docking, and molecular dynamics simulations.
• Evaluating physicochemical properties, allergenicity, and antigenicity of the designed constructs.

Main Results:

• The designed immunotoxins exhibited stable mRNA and reliable protein structures.
• Both constructs demonstrated high affinity and stable interactions with the EphA2 receptor, with construct 2 showing superior binding.
• The immunotoxins were found to be non-allergenic and antigenic.

Conclusions:

• The designed immunotoxins show potential as therapeutic agents for breast cancer.
• Construct 2 displays enhanced properties, suggesting it as a more promising candidate for further empirical investigation.
• These findings support the use of these immunotoxins in preclinical studies for breast cancer treatment.